Sign up to save your podcasts
Or
Share 231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market
Lawyer and bioethicist Holly Fernandez Lynch joins us to explain a watershed test of the FDA's authority to revoke drug approvals. And STAT's Helen Branswell calls in to discuss the headline-grabbing research at Boston University involving a lab-developed version of the virus that causes Covid-19.
View all episodes
By STAT
4.5
303303 ratings
Lawyer and bioethicist Holly Fernandez Lynch joins us to explain a watershed test of the FDA's authority to revoke drug approvals. And STAT's Helen Branswell calls in to discuss the headline-grabbing research at Boston University involving a lab-developed version of the virus that causes Covid-19.
More shows like The Readout Loud
View all
Planet Money
30,927 Listeners
a16z Podcast
1,023 Listeners
Odd Lots
1,777 Listeners
How I Built This with Guy Raz
30,242 Listeners
The Daily
111,310 Listeners
KFF Health News' 'What the Health?'
483 Listeners
The Long Run with Luke Timmerman
123 Listeners
Tradeoffs
383 Listeners
Biotech 2050 Podcast
59 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
30 Listeners
Raising Health
146 Listeners
Biotech Hangout
9 Listeners
Ground Truths
46 Listeners
Money Stuff: The Podcast
367 Listeners